Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Netherlands Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20042
20053
20064
20072
20103
20112
20122
20135
20142
20163
20172
20191
20202
20212
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting4
Active, not recruiting4
Terminated3
Unknown status3
Withdrawn2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Bristol-Myers Squibb7
Gruppo Italiano Malattie EMatologiche dell'Adulto3
Pfizer3
Ariad Pharmaceuticals2
Children's Oncology Group2
European LeukemiaNet2
Radboud University Medical Center2
Amsterdam UMC, location VUmc1
Commissie Voor Klinisch Toegepast Onderzoek1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive41
Leukemia9
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Bone Marrow Diseases4
Bronchiolitis Obliterans Syndrome4
Leukemia, Myeloid4
Leukemia, Myeloid, Chronic-Phase4
Myeloproliferative Disorders4
Philadelphia Chromosome4
Hematologic Diseases3

Trials

Showing 26 to 41 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.